Therapy Areas: Diabetes
Oramed Pharmaceuticals screens first patients in global Phase three trials of ORMD-0801
25 November 2020 - Oramed Pharmaceuticals Inc (Nasdaq/TASE: ORMP), a clinical-stage pharmaceutical company, has screened the first patients in its global Phase three trials of its oral insulin capsule...
Moderna Inks Supply Agreement with United Kingdom government to Supply mRNA Vaccine Against COVID-19 if Approved for Use
18 November 2020 - - US-based biotechnology company Moderna, Inc. (NASDAQ: MRNA) has inked a supply agreement with the government of the United Kingdom to supply mRNA-1273, its COVID-19 vaccine c...
Optomed gets Chinese regulatory approval for Optomed Aurora
13 November 2020 - Finnish medical technology company Optomed Plc (HEL:OPTOMED) has received medical devices regulatory approval in China for its latest generation handheld camera, Optomed Aurora, the...
Xbrane completes patient enrolment in phase III trial of biosimilar candidate Xlucane
12 November 2020 - Xbrane Biopharma AB (STO:XBRANE) has enrolled all of the planned 580 patients in XPLORE, the pivotal phase III trial for its biosimilar candidate Xlucane, the Swedish biopharmaceuti...
Moderna Has Completed Case Accrual for First Planned Interim Analysis of its mRNA Vaccine Against COVID-19 (mRNA-1273)
11 November 2020 - - US-based biotechnology company Moderna, Inc., (NASDAQ: MRNA) has completed case accrual for the first interim analysis of the Phase 3 COVE study of mRNA-1273, its COVID-19 vaccine...
Reven Pharmaceuticals Touts Positive Results Regarding the Clinical Safety and Preclinical Efficacy of Its COVID-19 Drug Candidate Rejuveinix
11 November 2020 - - The medical journal, Frontiers in Pharmacology has published peer-reviewed article in which a team from US-based biotechnology and pharmaceutical company Reven Holdings, Inc ...